Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | SIGLEC15 |
Upstream (Parents) |
---|
(<<) CCNB1 → SIGLEC15 |
(<<) CDK8 → SIGLEC15 |
(<<) CNIH4 → SIGLEC15 |
(<<) CXADR → SIGLEC15 |
(<<) GLTPD1 → SIGLEC15 |
(<<) HSPB1 → SIGLEC15 |
(<<) IMPA1 → SIGLEC15 |
(<<) MAPK12 → SIGLEC15 |
(<<) MEGF6 → SIGLEC15 |
(<<) MYC → SIGLEC15 |
(<<) MYL7 → SIGLEC15 |
(<<) NBL1 → SIGLEC15 |
(<<) NDST1 → SIGLEC15 |
(<<) PIK3CA → SIGLEC15 |
(<<) PROCR → SIGLEC15 |
(<<) SLC7A5 → SIGLEC15 |
(<<) SLMO2 → SIGLEC15 |
(<<) TCF7L1 → SIGLEC15 |
(<<) ZNF467 → SIGLEC15 |
Downstream (Children) |
---|
SIGLEC15 → DLX2 (>>) |
SIGLEC15 → GPX2 (>>) |
SIGLEC15 → GSTM3 (>>) |
SIGLEC15 → HSPA2 (>>) |
SIGLEC15 → INSR (>>) |
SIGLEC15 → ITGA3 (>>) |
SIGLEC15 → NCOR2 (>>) |
SIGLEC15 → NRIP3 (>>) |
SIGLEC15 → PHLDA1 (>>) |
SIGLEC15 → PKIG (>>) |
SIGLEC15 → PLA2G3 (>>) |
SIGLEC15 → PPP3CC (>>) |
SIGLEC15 → S100P (>>) |
SIGLEC15 → TFPI2 (>>) |